ScienceOpen: research and publishing network

For Researchers

Search
Advanced search

6

views

    

0

recommends

0

shares

Record: found
Abstract: found
Article: not found

Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.

Author(s): Menno A. Kiel, Esther Röder, Roy Gerth van Wijk, Maiwenn J Al, Wim C J Hop, Maureen P. M. H. Rutten-van Mölken, Beatriz Cara

Publication date: 2013-08-01

Journal: The Journal of Allergy and Clinical Immunology

Publisher: Elsevier BV

Keywords: Allergic rhinitis, adherence, TP, sublingual allergen immunotherapy, Tree pollen, House dust mite, specific allergen immunotherapy, World Health Organization, SCIT, WHO, HR, sublingual, SES, GP, persistence, Hazard rate, compliance, SLIT, HDM, cost, Grass pollen, Sublingual allergen immunotherapy, Socioeconomic status, Subcutaneous allergen immunotherapy, subcutaneous, subcutaneous allergen immunotherapy

Read this article at

ScienceOpenPublisher PubMed

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Subcutaneous allergen immunotherapy (SCIT) and sublingual allergen immunotherapy (SLIT) are safe and effective treatments of allergic rhinitis, but high levels of compliance and persistence are crucial to achieving the desired clinical effects.

Related collections

Author and article information

Journal

PubMed ID:: 23651609

DOI:: 10.1016/j.jaci.2013.03.013

Keywords: Allergic rhinitis,adherence,TP,sublingual allergen immunotherapy,Tree pollen,House dust mite,specific allergen immunotherapy,World Health Organization,SCIT,WHO,HR,sublingual,SES,GP,persistence,Hazard rate,compliance,SLIT,HDM,cost,Grass pollen,Sublingual allergen immunotherapy,Socioeconomic status,Subcutaneous allergen immunotherapy,subcutaneous,subcutaneous allergen immunotherapy

Comments

Comment on this article

scite_